GLP-1 Drugs May Block Long COVID Lung Damage: What July 2026 Research Reveals
A July 12, 2026 study found GLP-1 drugs may block inflammatory lung scarring from COVID-19 and reduce long COVID risk in diabetics. A 40-year pharmacist explains the research, the proposed mechanisms, and what the 7+ million Americans with long COVID symptoms should know.